Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688293 Shanghai OPM Biosciences
- 41.10
- +0.59+1.46%
Market Closed May 15 15:00 CST
4.67BMarket Cap289.44P/E (TTM)
41.81High40.41Low4.69KlotVolume40.51Open40.51Pre Close19.26MTurnover0.61%Turnover Ratio222.16P/E (Static)113.55MShares48.6752wk High2.21P/B3.18BFloat Cap24.5052wk Low48.61Limit Up77.41MShs Float97.48Historical High32.41Limit Down3.46%Amplitude24.50Historical Low0.45Dividend TTM41.08Avg Price1.94KlotAsk1.10%Div YieldTTM100Lot Size2.49KlotBid
Shanghai OPM Biosciences Stock Forum
Sign in to post a comment
Despite positive average three-year growth, Shanghai OPM Biosciences may be risky to invest at current price due to high P/S ratio and less optimistic growth forecast. This overvaluation might lead to potential disappointment for investors.
Shanghai OPM Biosciences' low ROE may alarm investors. Yet, sharp net income rise, perhaps from management choices or minor payout rate, stands out. High-return reinvestment could be driving its earnings surge.
No comment yet
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Boganji4 : can't help me